ArticleFrontiers in oncology2026
Efficacy of TKIs in non-small cell lung cancer with atypical EGFR p.L747P and p.L747S mutations.
Qiongxia Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleFrontiers in oncology2026
Qiongxia Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.